Book contents
- Common Pitfalls in Cerebrovascular Disease
- Common Pitfalls in Cerebrovascular Disease
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- 1 Transient ischemic attacks and stroke mimics and chameleons
- 2 Recognizing transient ischemic attacks in children and young adults
- 3 Transient ischemic attacks (TIAs) – an underrecognized and undertreated disorder
- 4 When the diagnostic image is not diagnostic
- 5 Choosing appropriate patients for anticoagulation
- 6 Antithrombotic management of recurrent atherothrombotic cerebrovascular disease
- 7 Common pitfalls in intravenous thrombolysis for acute ischemic stroke
- 8 Dilemmas in endovascular stroke therapy
- 9 Choosing the right patients for carotid artery procedural interventions
- 10 Stroke and patent foramen ovale: the conundrum of closure
- 11 The diagnosis and overdiagnosis of cerebral vasculitis
- 12 Recognizing cerebrovascular etiologies of “thunderclap” headaches
- 13 Underdiagnosis of reversible cerebral vasoconstriction syndromes
- 14 Moyamoya disease and other non-atherosclerotic cerebral vasculopathies
- 15 Vascular dementia and vascular cognitive impairment
- 16 Pitfalls in the diagnosis of subarachnoid hemorrhage
- 17 Managing hemorrhagic stroke
- 18 Managing patients or managing the results of ancillary tests?
- Index
- References
5 - Choosing appropriate patients for anticoagulation
Published online by Cambridge University Press: 05 August 2015
Book contents
- Common Pitfalls in Cerebrovascular Disease
- Common Pitfalls in Cerebrovascular Disease
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- 1 Transient ischemic attacks and stroke mimics and chameleons
- 2 Recognizing transient ischemic attacks in children and young adults
- 3 Transient ischemic attacks (TIAs) – an underrecognized and undertreated disorder
- 4 When the diagnostic image is not diagnostic
- 5 Choosing appropriate patients for anticoagulation
- 6 Antithrombotic management of recurrent atherothrombotic cerebrovascular disease
- 7 Common pitfalls in intravenous thrombolysis for acute ischemic stroke
- 8 Dilemmas in endovascular stroke therapy
- 9 Choosing the right patients for carotid artery procedural interventions
- 10 Stroke and patent foramen ovale: the conundrum of closure
- 11 The diagnosis and overdiagnosis of cerebral vasculitis
- 12 Recognizing cerebrovascular etiologies of “thunderclap” headaches
- 13 Underdiagnosis of reversible cerebral vasoconstriction syndromes
- 14 Moyamoya disease and other non-atherosclerotic cerebral vasculopathies
- 15 Vascular dementia and vascular cognitive impairment
- 16 Pitfalls in the diagnosis of subarachnoid hemorrhage
- 17 Managing hemorrhagic stroke
- 18 Managing patients or managing the results of ancillary tests?
- Index
- References
- Type
- Chapter
- Information
- Common Pitfalls in Cerebrovascular DiseaseCase-Based Learning, pp. 53 - 61Publisher: Cambridge University PressPrint publication year: 2015
References
1.Eikelboom, JW, Connolly, SJ, Brueckmann, M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013;369:1206–14.CrossRefGoogle ScholarPubMed
2.Mischie, AN, Chioncel, V, Droc, I, Sinescu, C. Anticoagulation in patients with dilated cardiomyopathy, low ejection fraction, and sinus rhythm: back to the drawing board. Cardiovasc Ther 2013;31(5):298–302.CrossRefGoogle Scholar
3.Massie, BM, Krol, WF, Ammon, SE. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail 2004;10(2):101–12.CrossRefGoogle ScholarPubMed
4.Pullicino, PM, Thompson, JL, Sacco, RL, et al. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial. Cerebrovasc. Dis. Basel Switz 2013; 36:74–8.Google ScholarPubMed
5.January, CT, Wann, LS, Alpert, JS, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation; published online March 28, 2014.Google Scholar
6.Diener, HC, Eikelboom, J, Connolly, SJ, et al. AVERROES Steering Committee and Investigators. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol 2012;11(3):225–31.CrossRefGoogle Scholar
7.Healey, , J. A Comparison of Apixaban Versus Aspirin for Preventing Stroke in Patients With Pacemakers (ARTESiA). NCT01938248. (2013). At http://clinicaltrials.gov/show/NCT01938248.Google Scholar
8.Granger, CB et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806–17.Google Scholar
9.Connolly, SJ, Ezekowitz, MD, Yusuf, S. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.CrossRefGoogle ScholarPubMed
10.US FDA. FDA Drug Safety Communication: FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin. (2014). At www.fda.gov/Drugs/DrugSafety/ucm396470.htm.Google Scholar
11.Giugliano, RP, Ruff, CT, Braunwald, E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369:2093–104.CrossRefGoogle ScholarPubMed
12.Patel, MR, Mahaffey, KW, Garg, J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883–91.CrossRefGoogle ScholarPubMed
13.Skjoth, F, Larsen, TB, Rasmussen, LH, Lip, GYH. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis. Thromb Haemost 2014;111:981–8.Google ScholarPubMed
14.Lip, GY, Manning, WJ, Weissman, NJ. Left ventricular thrombus after acute myocardial infarction. (2014). At www.uptodate.com/contents/left-ventricular-thrombus-after-acute-myocardial-infarction.Google Scholar
15.Shacham, Y, Leshem-Rubinow, E, Ben Assa, E, et al. Frequency and correlates of early left ventricular thrombus formation following anterior wall acute myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2013;111:667–70.CrossRefGoogle ScholarPubMed
16.Buss, NI, Friedman, SE, Andrus, BW, DeVries, JT. Warfarin for stroke prevention following anterior ST-elevation myocardial infarction. Coron Artery Dis 2013;24:636–641.CrossRefGoogle ScholarPubMed
17.Charidimo, A, Shakeshaft, C, Werring, DJ. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol 2012;3:133. eCollection 2012.Google Scholar